WO1993001283A1 - Plantes transgeniques sans genes de selection - Google Patents
Plantes transgeniques sans genes de selection Download PDFInfo
- Publication number
- WO1993001283A1 WO1993001283A1 PCT/US1992/005640 US9205640W WO9301283A1 WO 1993001283 A1 WO1993001283 A1 WO 1993001283A1 US 9205640 W US9205640 W US 9205640W WO 9301283 A1 WO9301283 A1 WO 9301283A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- plant
- selection
- vector
- expression system
- Prior art date
Links
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 162
- 238000000034 method Methods 0.000 claims abstract description 36
- 241000196324 Embryophyta Species 0.000 claims description 163
- 230000014509 gene expression Effects 0.000 claims description 60
- 239000013598 vector Substances 0.000 claims description 44
- 108010091086 Recombinases Proteins 0.000 claims description 31
- 239000003550 marker Substances 0.000 claims description 31
- 102000018120 Recombinases Human genes 0.000 claims description 26
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 21
- 230000001131 transforming effect Effects 0.000 claims description 11
- 230000008929 regeneration Effects 0.000 claims description 6
- 238000011069 regeneration method Methods 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 5
- 230000001404 mediated effect Effects 0.000 claims description 4
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 230000010154 cross-pollination Effects 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims 5
- 230000001747 exhibiting effect Effects 0.000 claims 3
- 230000010153 self-pollination Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 7
- 108090000790 Enzymes Proteins 0.000 abstract description 7
- 238000012546 transfer Methods 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 3
- 241000702191 Escherichia virus P1 Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 44
- 239000013612 plasmid Substances 0.000 description 24
- 230000009466 transformation Effects 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 22
- 241000589158 Agrobacterium Species 0.000 description 16
- 108060001084 Luciferase Proteins 0.000 description 14
- 229930027917 kanamycin Natural products 0.000 description 14
- 229960000318 kanamycin Drugs 0.000 description 14
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 14
- 229930182823 kanamycin A Natural products 0.000 description 14
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 11
- 239000005089 Luciferase Substances 0.000 description 10
- 239000012634 fragment Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 210000001938 protoplast Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 238000005204 segregation Methods 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- 108700009124 Transcription Initiation Site Proteins 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 101150047832 hpt gene Proteins 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 239000013605 shuttle vector Substances 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 240000003768 Solanum lycopersicum Species 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100001222 nononcogenic Toxicity 0.000 description 4
- 230000008488 polyadenylation Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 238000000844 transformation Methods 0.000 description 4
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 238000010222 PCR analysis Methods 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 108700026226 TATA Box Proteins 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 241001233957 eudicotyledons Species 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000000392 somatic effect Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000012252 genetic analysis Methods 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 230000008261 resistance mechanism Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- 230000005030 transcription termination Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229930192334 Auxin Natural products 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108700003860 Bacterial Genes Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108091027551 Cointegrate Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010046276 FLP recombinase Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- VPRLICVDSGMIKO-UHFFFAOYSA-N Mannopine Natural products NC(=O)CCC(C(O)=O)NCC(O)C(O)C(O)C(O)CO VPRLICVDSGMIKO-UHFFFAOYSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010034634 Repressor Proteins Proteins 0.000 description 1
- 102000009661 Repressor Proteins Human genes 0.000 description 1
- 241001633102 Rhizobiaceae Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 108010016634 Seed Storage Proteins Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical class N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- VPRLICVDSGMIKO-SZWOQXJISA-N mannopine Chemical compound NC(=O)CC[C@@H](C(O)=O)NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO VPRLICVDSGMIKO-SZWOQXJISA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 210000000745 plant chromosome Anatomy 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- FRGKKTITADJNOE-UHFFFAOYSA-N sulfanyloxyethane Chemical compound CCOS FRGKKTITADJNOE-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
Definitions
- the invention is directed to materials and methods which produce transgenic plants containing only desired foreign genes and which are free of unwanted or irrelevant selection genes. Advantage is taken of recombinase systems which permit the excision and segregation of selection gene DNA from introduced genetic material.
- Transgenic plants have been obtained which are insect resistant, for example, due to the presence of a gene from Bacillus thurin ⁇ iensis that confers such insect resistance.
- the nutritional value of various plants has also been improved by insertion of genes encoding proteins rich in desired amino acids.
- Introduction of genes encoding viral resistance mechanisms, herbicide resistance mechanisms, improved growth characteristics and the like are all desirable outcomes that can be achieved within the parameters of conventional technology in at least illustrative cases. Included within the parameters of current technology is, however, the necessity of transferring, along with the desired DNA, DNA encoding a selection gene and means for its expression to permit the efficient recovery of successful transformants.
- the present invention removes this source of environmental impact uncertainty by providing a method for excision and segregation of the selection gene which, after the initial transformation, has outlived its usefulness.
- the invention takes advantage of recombinase systems which are capable of excising marked DNA sequences.
- Cre/lox system One efficient system for excision of unwanted DNA sequences that has been widely employed generally is the Cre/lox system.
- This system illustrative of the general process, comprises "lox" marker sequences that, when included in a DNA sequence per se, mark the DNA which they bracket for excision or inversion (depending on the orientation of the lox sequences) by a corres ⁇ ponding "Cre" recombinase enzyme.
- recombinase/marker systems are available from a variety of sources and are functional in a number of hosts.
- the present invention specifically takes advantage of such recombinase/marker systems to excise and segregate selection genes in higher plants.
- the invention includes a means to control the nature of transgenic plants so as to provide plants which contain only the desired transgenic material and lack the selection genes useful in conducting the transformations necessary for their preparation.
- the resulting plants thus have more predictable environmental effects than those previously available in the art.
- the invention methods take advantage of recombinase/marker systems for excision and segregation of selection marker genes.
- the invention is directed to vectors suitable for transformation of higher plants which comprise selection genes marked by DNA marker sequences which form a part of a recombinase/marker system.
- the selection gene is further linked to control sequences which are capable of effecting its expression so that it can be used in the selection of transformed plants prior to excision.
- the invention also includes these vectors that further contain an expression system for a desired gene.
- the invention is also directed to plant cells or cultures in regenerated plants transformed with the vectors of the invention and to plant cells and plants which are further transformed with expression vectors that include the gene for the recombinase enzyme associated with the recombinase marker system.
- the invention is also directed to methods to produce such transformants and to segregate the selection gene from the desired gene in progeny.
- Figure 1 is a schematic showing the construction of pED37 and pED53. As indicated in Figure 1, the pED37 oriented as shown will be inserted into the Sail site of pED53 in the recombined vector pED53: :pED37.
- Figure 2A shows the positioning of the insert from pED53::pED37 into the host genome and the expected sizes of PCR products obtained from primers as described in the examples hereinbelow.
- Figure 2B shows the expected orientation of this insert in the gene after excision of the hpt selection gene. The expected PCR product size is also shown.
- Figure 3 shows the sequence of the amplified portions indicated in Figures 2A and 2B.
- the invention is directed to methods which result in transgenic plants that are capable of expressing a desired gene but that are free of genes associated with the transformation process as "selectable markers.”
- the invention methods provide, therefore, plants having conferred characteristics which are limited to those desired to be achieved by the transformation and not associated with unrelated, and perhaps unwanted selection characteristics.
- plants are obtained by either of two related methods. Both methods require that the selection gene associated with the initial transformation with the desired gene be operably linked to marker DNA sequences that mark the gene for excision mediated by a corresponding recombinase enzyme. In both methods, therefore, plants or plant cells are initially transformed with a recombinant vector which contains a selection characteristic gene operably linked to marker
- the vector further includes an expression system which comprises the desired gene operably linked to appropriate control sequences.
- the expression systems must be operable in higher plant cells.
- initially transformed plant cells or plants can be further transformed in a second round of transformation with a second recombinant vector which contains the recombinase gene that corresponds to the DNA sequences that mark the selection gene for excision.
- a second selection gene needs to be included so that the second round of transformation can be verified.
- the successful second transformants for the most part, will be free of the first selection marker due to the operation of the recombinase product of the recombinase gene.
- progeny are screened for freedom from the second selection marker as well.
- the second selection marker is not linked to the desired gene construct, it is segregated from the desired gene in the progeny.
- this first approach is conducted by transformation of plant cells, and regenerating the screened progeny into intact plants.
- the second transformants can first be regenerated into plants and self-pollinated to produce the segregated progeny.
- regenerated plants from the first and second transformations (which are conducted independently) are cross-pollinated to effect the excision of the first selection marker.
- the progeny of the products of this cross-pollination that show expression of the desired gene can then be screened for the absence of the second selection gene. As the desired gene and the second selection gene are not linked, segregation occurs in these second generation progeny.
- selection characteristic gene refers to a gene which produces a product that confers on a host containing it a selectable property such as herbicide or antibiotic resistance.
- Suitable selection genes for methods of the invention include genes encoding hygromycin resistance (the hpt gene) or kanamycin resistance (nptll gene) and any other gene which confers such characteristics on higher plant cells.
- a “desired gene” is a gene that may encode a protein or an RNA, the presence of which is desired in the finished plant. Such genes may include those encoding seed storage proteins, those encoding insect resistance, or any other gene which is thought to confer desired characteristics on the plant containing it.
- expression system has its usual meaning--i.e. , DNA which contains the coding sequence of a gene operably linked to control systems which effect the expression of the gene in the higher plant cells.
- control sequences include a promoter, and optionally, additional sequences which aid in expression such as polyadenylation sites, or other appropriate control sequences.
- Marker DNA sequences refer to sequences that, when present in proper orientation with respect to included DNA, mark the gene for excision or inversion when in the presence of an appropriate corresponding enzyme.
- Corresponding recombinase refers to the enzyme which is capable of recognizing the marker DNA sequences and excising or inverting the included DNA. Illustrated herein is the system that includes the lox DNA sequences corresponding to the ere recombinase enzyme, but a multiplicity of such systems are known. These are reviewed, for example, by Craig, Annual Review of Genetics (1988) 22.:77-105. Any such system operable in higher plants may be used.
- control regions which are functional either constitutively are employed.
- Transcription initiation regions include the various opine initiation regions, such as octopine, mannopine, nopaline and the like.
- Plant viral promoters can also be used, such as the cauliflower mosaic virus 35S promoter.
- a large number of suitable control systems are available.
- the cauliflower mosaic virus (CaMV) 35S promoter has been shown to be highly active in many plant organs and during many stages of development when integrated into the genome of transgenic plants including tobacco and petunia, and has been shown to confer expression in protoplasts of both dicots and monocots.
- Organ-specific promoters are also well known, but may be less convenient.
- the E8 promoter is only transcriptionally activated during tomato fruit ripening, and can be used to target gene expression in ripening tomato fruit (Deikman and Fischer, EMBO J (1988) 7:3315; Giovannoni et al., The Plant Cell (1989) 1:53).
- the activity of the E8 promoter is not limited to tomato fruit, but is thought to be compatible with any system wherein ethylene activates biological processes.
- Either a constitutive promoter (such as the CaMV or Nos promoter illustrated above) or a desired organ-specific promoter (such as the E8 promoter from tomato) is then ligated to the gene to be expressed using standard techniques now common in the art.
- the expression system may be further optimized by employing supplemental elements such as transcription terminators and/or enhancer elements.
- the recombinant expression cassette will contain in addition to the coding sequence, a plant promoter region, a transcription initiation site (if the coding sequence to be transcribed lacks one) , and a transcription termination sequence.
- TATAAT TATAAT
- bp base pairs upstream of the transcription start site.
- the start site is called +1. Sequences extending in the 5' (upstream) - direction are given negative numbers and sequences extending in the 3' (downstream) direction are given positive numbers.
- the promoter is preferably positioned about the same distance from the heterologous transcription start site as it is from the transcription start site in its natural setting. As is known in the art, however, some variation in this distance can be accommodated without loss of promoter function.
- any of a number of promoters which direct transcription in plant cells is suitable.
- the promoter can be either constitutive or inducible.
- Promoters of bacterial origin include the octopine synthase promoter, the nopaline synthase promoter and other promoters derived from native Ti plasmids (Herrera-Estrella et al., Nature (1983) 3_03.:209-213) .
- Viral promoters include the 35S and 19S RNA promoters of cauliflower mosaic virus (O'Dell et al.. Nature (1985) 313:810-812) .
- Plant promoters include the ribulose-l,3-disphosphate carboxylase small subunit promoter and the phaseolin promoter.
- the expres- sion cassette should also contain a transcription termination region downstream of the structural gene to provide for efficient termination.
- the termination region may be obtained from the same gene as the promoter sequence or may be obtained from different genes.
- DNA sequences which direct polyadenylation of the RNA are also commonly added to the vector construct (Alber and Kawasaki, Mol and Appl Genet. (1982) 1:419-434) .
- Polyadenylation is of importance for expression of the transcription product RNA in plant cells. Polyadenylation sequences include, but are not limited to the Agrobacterium octopine synthase signal (Gielen et al., EMBO J. (1984) 1:835-846) or the nopaline synthase signal (Depicker et al., Mol and Appl Genet (1982) 1,561-573) .
- the resulting expression system or cassette is ligated into or otherwise constructed to be included in a recombinant vector which is appropriate for higher plant transformation.
- the vector will also contain an expression system for a selection gene by which transformed plant cells can be identified in culture.
- the selection gene will encode antibiotic resistance, e.g., resistance to G418, hygromycin, bleomycin, kanamycin, and gentamicin. After transforming the plant cells, those cells having the vector will be identified by their ability to grow on a medium containing the particular antibiotic.
- Replication sequences of bacterial or viral origin, are generally also included to allow the vector to be cloned in a bacterial or phage host, preferably a broad host range procaryotic origin of replication is included.
- a selection gene suitable for bacteria should also be included to allow selection of bacterial cells bearing the desired construct. Suitable procaryotic selection genes also include resistance to antibiotics such as kanamycin or tetracycline.
- DNA sequences encoding additional func- tions may also be present in the vector, as is known in the art.
- T-DNA sequences will also be included for subsequent transfer to plant chromosomes.
- vectors can also be constructed that contain in-frame ligations between the coding sequence of the desired gene and sequences encoding other molecules of interest resulting in fusion proteins, by techniques well known in the art.
- transgenic plants are prepared which contain the desired expression system.
- a number of techniques are available for transformation of plants or plant cells. All types of plants are appropriate subjects for "direct” transformation; in general, only dicots can be transformed using Agrobacterium-mediated infection.
- the vector is microinjected directly into plant cells by use of micropipettes to mechanically transfer the recombinant
- the genetic material is transferred into the plant cell using polyethylene glycol (Krens, et al., Nature (1982) 296:72-74) , or high velocity ballistic penetration by small particles with the nucleic acid either within the matrix of small beads or particles, or on the surface, is used (Klein, et al., Nature (1987) 327:70-73) .
- protoplasts are fused with other entities which contain the DNA whose introduction is desired. These entities are minicells, cells, lysosomes or other fusible lipid-surfaced bodies (Fraley, et al., Proc Natl Acad Sci USA (1982)
- DNA may also be introduced into the plant cells by electroporation (Fromm et al., Proc Natl Acad Sci USA (1985) 32:5824) .
- plant protoplasts are electroporated in the presence of plasmids containing the expression cassette. Electrical impulses of high field strength reversibly permeabilize biomembranes allowing the introduction of the plasmids. Electroporated plant protoplasts reform the cell wall, divide, and regenerate.
- a plant cell For transformation mediated by bacterial infec ⁇ tion, a plant cell is infected with Agrobacterium tumefaciens or A. rhizogenes previously transformed with the DNA to be introduced.
- Agrobacterium is a representative genus of the gram-negative family Rhizobiaceae. Its species are responsible for crown gall (A. tumefaciens) and hairy root disease (A. rhizogenes) .
- the plant cells in crown gall tumors and hairy roots are induced to produce amino acid derivatives known as opines, which are catabolized only by the bacteria.
- the bacterial genes responsible for expression of opines are a convenient source of control elements for chimeric expression cassettes.
- assaying for the presence of opines can be used to identify transformed tissue.
- Heterologous genetic sequences can be introduced into appropriate plant cells, by means of the Ti plasmid of A. tumefaciens or the Ri plasmid of A. rhizogenes.
- the Ti or Ri plasmid is transmitted to plant cells on infection by Agrobacterium and is stably integrated into the plant genome (Schell, J., Science (1987) 237:1176-1183) .
- Ti and Ri plasmids contain two regions essential for the production of transformed cells. One of these, named transferred DNA (T-DNA) , is transferred to plant nuclei and induces tumor or root formation. The other, termed the virulence (vir) region, is essential for the transfer of the T-DNA but is not itself transferred.
- T-DNA transferred DNA
- vir virulence
- the T-DNA will be transferred into a plant cell even if the vir region is on a different plasmid (Hoekema, et al., Nature (1983) 303:179-189) .
- the transferred DNA region can be increased in size by the insertion of heterologous DNA without its ability to be transferred being affected.
- a modified Ti or Ri plasmid in which the disease-causing genes have been deleted, can be used as a vector for the transfer of the • gene constructs of this invention into an appropriate plant cell. Construction of recombinant Ti and Ri plasmids in general follows methods typically used with the more common bacterial vectors, such as pBR322. Additional use can be made of accessory genetic elements sometimes found with the native plasmids and sometimes constructed from foreign sequences.
- shuttle vectors may include but are not limited to "shuttle vectors,” (Ruvkum and Ausubel, Nature (1981) 211:85-88), promoters (Lawton et al., Plant Mol Biol (1987) 9_:315-324) and structural genes for antibiotic resistance as a selection factor (Fraley et al., Proc Natl Acad Sci (1983) 10:4803-4807) .
- cointegrate the shuttle vector containing the gene of interest is inserted by genetic recombination into a non- oncogenic Ti plasmid that contains both the cis-acting and trans-acting elements required for plant transformation as, for example, in the pMLJl shuttle vector of DeBlock et al., EMBO J (1984) 1:1681-1689 and the non-oncogenic Ti plasmid pGV3850 described by Zambryski et al., EMBO J (1983) 2:2143-2150.
- the gene of interest is inserted into a shuttle vector containing the cis-acting elements required for plant transformation.
- the other necessary functions are provided in trans by the non- oncogenic Ti plasmid as exemplified by the pBIN19 shuttle vector described by Bevan, Nucleic Acids Research (1984) 12:8711-8721 and the non-oncogenic Ti plasmid PAL4404 described by Hoekema, et al.. Nature (1983) 303:179-180.
- the first requires an established culture system that allows for culturing protoplasts and subsequent plant regeneration from cultured protoplasts.
- the second method requires (a) that the intact plant tissues, such as cotyledons, can be transformed by
- Agrobacterium and (b) that the transformed cells or tis ⁇ sues can be induced to regenerate into whole plants.
- Most dicot species can be transformed by
- a g robacterium as all species which are a natural plant host for Agrobacterium are transformable in vitro.
- Identification of transformed cells or plants is generally accomplished by including a selectable marker in the transforming vector, or by obtaining evidence of successful bacterial infection.
- Plant cells which have been transformed can also be regenerated using known techniques.
- Means for regeneration vary from species to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing transformed explants is first provided. Callus tissue is formed and shoots may be induced from callus and subsequently rooted. Alternatively, somatic embryo formation can be induced in the callus tissue. These somatic embryos germinate as natural embryos to form plants.
- the culture media will generally contain various amino acids and plant hormones, such as auxin and cytokinins. It is also advantageous to add glutamic acid and proline to the medium, especially for such species as corn and alfalfa. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these three variables are controlled, then regeneration is usually reproducible and repeatable.
- the expression cassette After the expression cassette is stably incorporated into regenerated transgenic plants, it can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.
- Plasmid pED23 which contains the expression system for the ere gene was constructed as described by Dale, E.D. and Ow, D.W., Gene (1990) 11:79-85. This plasmid uses a pUC19 host vector (Yanich-Perron, C. et al. Gene (1985) 11:103-119) and utilizes a 35S promoter to transcribe a Cre-nos3' fusion.
- the plasmid pED53 is constructed from the Agrobacterium gene transfer vector pBIN19, the construction of which was described by Bevan, M. , Nucleic Acids Res (1984) 12:8711-8721. To convert pBIN19 to pED53, a 1.3 kb Pstl fragment was deleted. The deletion removes part of the T-DNA including the coding region of the kanamycin resistance gene (nptll) along with Hindlll and Sphl sites. Plasmid pED37 was constructed from pED26, which contains the luciferase expression system and has been described by Dale, E.C. and Ow, D.W.
- the co-integrate plasmid pED53::pED37 was formed by linearizing pED37 at an Xhol site adjacent to one of the lox sites and inserting it into the Sail site of pED53.
- pED37 contains the 35S promoter operably linked to the luciferase gene which is in turn terminated by the nos3' sequence. Bracketed by the lox sites are ampicillin resistance, and the hpt expression system.
- the pED37 is co-integrated into pED53 between the right and left border (RB and LB) regions in the orientation shown.
- the co-integrate plasmid which supplies the ere gene, pBINl9: :pED23 was obtained by ligating the Hindlll linearized pED23 into the Hindlll site of pBIN19 so that the transcription of the ere gene is directed toward the Agrobacterium LB.
- the co-integrate plasmids were selected by ability to confer resistance to both kanamycin and ampicillin in bacteria. This selection is facilitated by transformation into the J . coli polymerase I-deficient host JZ294 (argH, strA, polA: :Tnl0) which permits replication of the wide host range replicons of pED53 and pBIN19 but not the ColEl replicons of pED37 and pED23.
- the co-integrate plasmids pED53::pED37 and pBIN19: :pED23 were mobilized into Agrobacterium tumefaciens strain GV3111(pTiB6S3SE) for infection of Nicotiana tabacum (Wisconsin-38 cultivar) leaf explants as described by Horsch, R.B. et al. Science (1985) 227:229-231. Hyg and Kan plants were scored for the ability of leaf explants to form shoots on shoot- inducing MS media containing antibiotics (20 ⁇ g/ml hygromycin sulfate or 100 ⁇ g/ml kanamycin sulfate) .
- Luc + plants were assayed for luciferase activity as described by Ow, D.W. et al., Science (1986) 14:856-859.
- ntED5337 hygromycin-resistant plants were obtained from transformation with pED53: :pED37. These are designated “ntED5337” plants. These plants contain the luciferase expression system and the hpt expression system incorporated into the genome in the configuration shown in Figure 2A. This was verified by genetic analysis as described below. The ntED5337 plants express the luciferase gene, and are hygromycin-resistant as required by the selection protocol.
- ntED5337 plants were transfected, using the protocol described above, with pED23. Successful transformants will be selectable for kanamycin resistance and are capable of production of the ere enzyme. The resulting transformants were thus selected by kanamycin . resistance and the kanamycin-resistant plants were then tested for hygromycin resistance as described above. Most of them, designated ntED5337-23, were hygromycin- sensitive. This showed that the introduction of the ere enzyme catalyzed recombination of the lox sites flanking the hygromycin resistance gene. The deleted DNA, no longer linked to the replicating host chromosome, is lost in the progeny cells deriving from the primary cell where the excision event occurred.
- ntED5337-23 plant cells or the regenerated plants express the gene encoding luciferase, however.
- plants regenerated from independent transformations by pED23::pED37 and pBIN19: :pED23, respectively, were cross- pollinated to obtain progeny.
- progeny Of 316 progeny examined, 78 produced luciferase and were kanamycin-resistant. Among these, 42 were hygromycin-sensitive. These 42 plants are substantially equivalent to those regenerated from the cellular progeny ntED5337-23.
- DNA was prepared by grinding leaf tissues in liquid N 2 , extracting with 100 mM Tris/1% SDS/50 mM EDTA/500 mM NaCl/10 mM 3-mercaptoethanol at 65°C, 10 min. , followed by adding potassium acetate to 1.3 M, chilling to 0°C and removing the debris by centrifugation. The DNA was then precipitated with isopropanol, washed with 70% ethanol and resuspended in 10 mM Tris/1.0 mM EDTA. Polymerase chain reactions were carried out under standard conditions as described by Saiki, R.K.
- GAGTGCACCATATGCGGTGT-3' C, 5' -GACGCCCCAGCACTCGTCCG-3' ; D, 5' -GGTACCCGGGATCCTCTAG-3' ; E, 5' -GTTCATTTCATTTGGAGAGG- 3'; F, 5'-CAGTGATACACATGGGGATC-3' .
- the two primers for detection of the ere gene (5' -ATGTCCAATTTACTGACCGT-3' and
- 5'-CTAATCGCCATCTTCCAGCA-3' represent the N and C- terminal ere coding sequence and the expected PCR product size is 1.0 kb.
- fragments from PCR reactions were purified, digested with appropriate restriction enzymes (A+B; BamHI/Ndel, C+D; Pstl/BamHI, A+D; Clal/BamHI) and ligated into either pUC19 (for A+B and C+D) or pBR322 (for A+D) .
- nucleotide sequences of the regions surrounding the lox sites derived form PCR reactions from plants ntED5337 and ntED5337-23 were determined by the dideoxy method as modified by U.S. Biochemical (Sequenase kit) .
- This band corresponds to the fragment expected from the joining of the chimeric luciferase gene with the sequence adjacent to the LB.
- Primers E+F were used to assay for the possibility that the hygromycin resistance gene might have translocated elsewhere in the genome; a fragment corresponding to the expected 0.56 kb band was found in the parent, but not in the descendent ntED5337-23. Thus, the excised hygromycin gene is not present in the genome at all. The excision event also removes the silent ampicillin resistance marker from the plant genome. Of five plants examined, the PCR profiles showed no indication of harboring both excised and intact copies as shown in Figure 2A and 2B suggesting that the excision must have occurred early between introduction of the ere-expressing construct and plant organogenesis.
- ntED5337 derived fragments produced from PCR amplification by primers A+B and primers C+D, as well as the ntED5337-23 derived fragment from primers A+D were cloned into plasmid vectors.
- Figure 3 shows the experimentally obtained sequences of the three different lox-containing regions.
- the lox regions derived form primers A+B and C+D share 80 bp of identity that include the 34 kb lox sequence, but diverge outside of this segment.
- each parental lox sequence is adjacent to one characteristic restriction site, either Sail or BamHI, but on opposite sides of the lox sequence.
- the lox sequence of the PCR product derived from primers A+D from ntED5337-23 DNA is flanked by both restriction sites and by sequences found in opposing sides of each of the parental ntED5337 lox sites.
- the recombination event within plant chromatin was conservative, i.e., without loss or alteration of the lox sequence or its flanking DNA. To our knowledge, this is the first description at the nucleotide sequence level of cre/lox- catalyzed recombination in eucaryotic chromosomal DNA.
- ntED5337-23 plants were self-pollinated to allow segregation of the luciferase gene from the ere locus which also harbors the linked nptll selection gene. Approximately 100 1 germinated seedlings from each self- pollinated plant were scored for luciferase activity. In both cases, about 3/4 of the total progeny produced luciferase and among these, approximately 1/4 were expected to be sensitive to kanamycin. This was the case with the progeny from one plant. From the second plant, however, only 1 out of approximately every luciferase producer progeny was sensitive to kanamycin.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Méthodes et matériaux pour la production de plantes transgéniques qui ne sont transgéniques qu'à l'égard de gènes étrangers dont on souhaite l'inclusion et ne comportant pas de gènes possédant des propriétés de sélection. On se sert des systèmes qui marquent l'ADN en vue de l'excision en combinaison avec les enzymes qui servent de médiateurs à l'excision pour séparer les gènes de sélection des gènes de transfert souhaité. En particulier, le système cre/lox du bactériophage P1 est utilisé pour illustrer cette méthode.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72532091A | 1991-07-08 | 1991-07-08 | |
US725,320 | 1991-07-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993001283A1 true WO1993001283A1 (fr) | 1993-01-21 |
Family
ID=24914062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/005640 WO1993001283A1 (fr) | 1991-07-08 | 1992-07-06 | Plantes transgeniques sans genes de selection |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2073412A1 (fr) |
WO (1) | WO1993001283A1 (fr) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004667A1 (fr) * | 1992-08-25 | 1994-03-03 | Kölner Verein Zur Förderung Der Immunologie | Remplacement cible d'un gene sans sequences residuelles selectionnables et sans endogenes |
EP0635574A1 (fr) * | 1993-07-23 | 1995-01-25 | Gist-Brocades N.V. | Souches récombinantes dépourvues de marqueurs de sélection: procédé pour leur obtention et utilisation de ces souches |
US5441884A (en) * | 1993-07-08 | 1995-08-15 | Ecogen Inc. | Bacillus thuringiensis transposon TN5401 |
EP0716147A2 (fr) | 1994-11-09 | 1996-06-12 | Nippon Paper Industries Co., Ltd. | Procédé de préparation des plantes transgéniques |
WO1996040877A1 (fr) * | 1995-06-07 | 1996-12-19 | California Institute Of Technology | Immortalisation et desimmortalisation de cellules |
WO1997037012A1 (fr) * | 1996-03-29 | 1997-10-09 | Commonwealth Scientific And Industrial Research Organisation | Procede d'excision en une seule etape |
WO1997042334A1 (fr) * | 1996-05-09 | 1997-11-13 | Nippon Paper Industries Co., Ltd. | Vecteur pour le transfert genique dans une plante, permettant la deletion eventuelle d'un gene marqueur |
WO1997041228A3 (fr) * | 1996-05-01 | 1997-12-11 | Pioneer Hi Bred Int | Utilisation de la proteine fluorescente verte comme marqueur de criblage pour la transformation de plantes |
US5776449A (en) * | 1993-07-08 | 1998-07-07 | Ecogen Inc. | Recombinant bacillus thuringiensis strains, insecticidal compositions and method of use |
FR2759857A1 (fr) * | 1997-02-27 | 1998-08-28 | Biocem | Nouvelles utilisations de la sterilite male chez les plantes |
EP0686191A4 (fr) * | 1993-01-29 | 1999-01-27 | Purdue Research Foundation | Modification controlee de genomes eukaryotes |
WO1999025840A1 (fr) * | 1997-11-18 | 1999-05-27 | Pioneer Hi-Bred International, Inc. | Nouveau procede d'integration d'adn etranger dans des genomes . |
AU717267B2 (en) * | 1996-03-29 | 2000-03-23 | Commonwealth Scientific And Industrial Research Organisation | Single-step excision means |
US6187994B1 (en) | 1997-11-18 | 2001-02-13 | Pioneer Hi-Bred International, Inc. | Compositions and methods for genetic modification of plants |
US6265218B1 (en) * | 1994-08-11 | 2001-07-24 | Roche Diagnostics Gmbh | Plasmids without a selection marker gene |
US6300545B1 (en) | 1997-11-18 | 2001-10-09 | Pioneer Hi-Bred International, Inc. | Mobilization of viral genomes from T-DNA using site-specific recombination systems |
WO2001040492A3 (fr) * | 1999-11-12 | 2002-02-07 | Univ Rockefeller | Recombinaison dirigee inductible destinee a l'activation et a l'elimination de transgenes de plantes transgeniques |
WO2002016624A1 (fr) * | 2000-08-25 | 2002-02-28 | Institute Of Molecular Agrobiology | Reduction de la transmission de transgenes dans des plantes |
US6410329B1 (en) | 1995-09-25 | 2002-06-25 | Novartis Finance Corporation | Method for achieving site specific integration of exogenous DNA delivered by non-biological means to plant cells |
US6632980B1 (en) | 1997-10-24 | 2003-10-14 | E. I. Du Pont De Nemours And Company | Binary viral expression system in plants |
EP1218488A4 (fr) * | 1999-09-21 | 2004-09-29 | Univ Rutgers | Systeme de recombinaison specifique au site permettant de manipuler le genome du plaste de plantes superieures |
EP1669456A2 (fr) | 2004-12-11 | 2006-06-14 | SunGene GmbH | Cassettes d'expression pour l'expression preférentielle dans les méristèmes de plantes |
US7102055B1 (en) | 1997-11-18 | 2006-09-05 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
CN1313610C (zh) * | 2004-06-24 | 2007-05-02 | 中国科学院微生物研究所 | 一种用于去除转基因植物中选择标记基因的方法 |
US7238854B2 (en) | 2002-04-11 | 2007-07-03 | E. I. Du Pont De Nemours And Company | Method of controlling site-specific recombination |
US7267979B2 (en) | 2002-07-01 | 2007-09-11 | Pioneer Hi-Bred International, Inc. | Method of controlling gene silencing using site specific recombination |
US7560622B2 (en) | 2000-10-06 | 2009-07-14 | Pioneer Hi-Bred International, Inc. | Methods and compositions relating to the generation of partially transgenic organisms |
US7736897B2 (en) | 2005-07-18 | 2010-06-15 | Pioneer Hi-Bred International, Inc. | FRT recombination sites and methods of use |
EP2256189A1 (fr) | 2003-03-28 | 2010-12-01 | National Institute Of Agrobiological Sciences | Procédé de production d'un organe de stockage de plante avec une production élevée de dérivé de GLP-1 recombinant. |
US7932434B2 (en) | 2007-08-15 | 2011-04-26 | Wisconsin Alumni Research Foundation | Late blight resistance gene from wild potato |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4959317A (en) * | 1985-10-07 | 1990-09-25 | E. I. Du Pont De Nemours And Company | Site-specific recombination of DNA in eukaryotic cells |
-
1992
- 1992-07-06 WO PCT/US1992/005640 patent/WO1993001283A1/fr active Application Filing
- 1992-07-08 CA CA 2073412 patent/CA2073412A1/fr not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4959317A (en) * | 1985-10-07 | 1990-09-25 | E. I. Du Pont De Nemours And Company | Site-specific recombination of DNA in eukaryotic cells |
Non-Patent Citations (3)
Title |
---|
BIO/TECHNOLOGY, Volume 7, No. 12, issued December 1989, P. KNIGHT, "Engineered Fruit and Vegetable Crops", pages 1233-1237. * |
MOLECULAR AND CELLULAR BIOLOGY, Volume 7, No. 6, issued June 1987, B. SAUER, "Functional Expression of the cre-lox Site-Specific Recombination System in the Yeast Saccharomyces Cerevisiae", pages 2087-2096. * |
NUCLEIC ACIDS RESEARCH, Volume 17, No. 1, issued 1989, B. SAUER AND N. HENDERSON, "Cre-Stimulated Recombination at loxP-Containing DNA Sequences Placed Into the Mammalian Genome", pages 147-161. * |
Cited By (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6570061B1 (en) | 1992-08-25 | 2003-05-27 | Klaus Rajewsky | Targeted replacement of an immunoglobulin gene without endogenous and selectable residual sequences in mice |
WO1994004667A1 (fr) * | 1992-08-25 | 1994-03-03 | Kölner Verein Zur Förderung Der Immunologie | Remplacement cible d'un gene sans sequences residuelles selectionnables et sans endogenes |
EP0686191A4 (fr) * | 1993-01-29 | 1999-01-27 | Purdue Research Foundation | Modification controlee de genomes eukaryotes |
US5776449A (en) * | 1993-07-08 | 1998-07-07 | Ecogen Inc. | Recombinant bacillus thuringiensis strains, insecticidal compositions and method of use |
US5650308A (en) * | 1993-07-08 | 1997-07-22 | Ecogen, Inc. | Recombinant Bacillus thuringiensis strain construction method |
US5441884A (en) * | 1993-07-08 | 1995-08-15 | Ecogen Inc. | Bacillus thuringiensis transposon TN5401 |
US5843744A (en) * | 1993-07-08 | 1998-12-01 | Ecogen Inc. | Bacillus thuringiensis Tn5401 proteins |
EP0635574A1 (fr) * | 1993-07-23 | 1995-01-25 | Gist-Brocades N.V. | Souches récombinantes dépourvues de marqueurs de sélection: procédé pour leur obtention et utilisation de ces souches |
EP1321523A3 (fr) * | 1993-07-23 | 2004-03-03 | DSM IP Assets B.V. | Souches récombinantes dépourvues de marqueurs de sélection: procédé pour leur obtention et utilisation de ces souches |
US6265218B1 (en) * | 1994-08-11 | 2001-07-24 | Roche Diagnostics Gmbh | Plasmids without a selection marker gene |
EP0716147A2 (fr) | 1994-11-09 | 1996-06-12 | Nippon Paper Industries Co., Ltd. | Procédé de préparation des plantes transgéniques |
WO1996040877A1 (fr) * | 1995-06-07 | 1996-12-19 | California Institute Of Technology | Immortalisation et desimmortalisation de cellules |
US6410329B1 (en) | 1995-09-25 | 2002-06-25 | Novartis Finance Corporation | Method for achieving site specific integration of exogenous DNA delivered by non-biological means to plant cells |
AU717267B2 (en) * | 1996-03-29 | 2000-03-23 | Commonwealth Scientific And Industrial Research Organisation | Single-step excision means |
WO1997037012A1 (fr) * | 1996-03-29 | 1997-10-09 | Commonwealth Scientific And Industrial Research Organisation | Procede d'excision en une seule etape |
WO1997041228A3 (fr) * | 1996-05-01 | 1997-12-11 | Pioneer Hi Bred Int | Utilisation de la proteine fluorescente verte comme marqueur de criblage pour la transformation de plantes |
US6486382B1 (en) | 1996-05-01 | 2002-11-26 | Pioneer Hi-Bred International, Inc. | Use of the green fluorescent protein as a screenable marker for plant transformation |
AU728915B2 (en) * | 1996-05-09 | 2001-01-18 | Nippon Paper Industries Co. Ltd. | Vector for introducing a gene into a plant from which a selectable marker gene can be optionally removed |
WO1997042334A1 (fr) * | 1996-05-09 | 1997-11-13 | Nippon Paper Industries Co., Ltd. | Vecteur pour le transfert genique dans une plante, permettant la deletion eventuelle d'un gene marqueur |
US7112719B2 (en) | 1997-02-27 | 2006-09-26 | Biogemma | Use of male sterility to prevent transgene spread in plants |
WO1998038323A3 (fr) * | 1997-02-27 | 1998-12-17 | Biocem | Nouvelles utilisations de la sterilite male chez les plantes |
FR2759857A1 (fr) * | 1997-02-27 | 1998-08-28 | Biocem | Nouvelles utilisations de la sterilite male chez les plantes |
US6632980B1 (en) | 1997-10-24 | 2003-10-14 | E. I. Du Pont De Nemours And Company | Binary viral expression system in plants |
US6573425B1 (en) | 1997-11-18 | 2003-06-03 | Pioneer Hi-Bred International, Inc. | Compositions and methods to reduce the complexity of transgene integration in the genome of a plant |
US7820880B2 (en) | 1997-11-18 | 2010-10-26 | Pioneer Hi-Bred Int'l. Inc. | Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant |
US6455315B1 (en) | 1997-11-18 | 2002-09-24 | Pioneer Hi-Bred International, Inc. | Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant |
US6458594B1 (en) | 1997-11-18 | 2002-10-01 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted removal of a nucleotide sequence from the genome of a plant |
US9222098B2 (en) | 1997-11-18 | 2015-12-29 | Christopher L. Baszczynski | Compositions for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
US6541231B1 (en) | 1997-11-18 | 2003-04-01 | Pioneer Hi-Bred International, Inc. | Method for the integration of foreign DNA into eukaryotic genomes |
US6552248B1 (en) | 1997-11-18 | 2003-04-22 | Pioneer Hi-Bred International, Inc. | Compositions and methods for locating preferred integration sites within a plant genome |
US6331661B1 (en) | 1997-11-18 | 2001-12-18 | Pioneer Hi-Bred International, Inc. | Method for directional stable transformation of eukaryotic cells |
US6300545B1 (en) | 1997-11-18 | 2001-10-09 | Pioneer Hi-Bred International, Inc. | Mobilization of viral genomes from T-DNA using site-specific recombination systems |
US6624297B1 (en) | 1997-11-18 | 2003-09-23 | Pioneer Hi-Bred International, Inc. | Compositions for the genetic modification of plants |
US6262341B1 (en) | 1997-11-18 | 2001-07-17 | Pioneer Hi-Bred International, Inc. | Method for the integration of foreign DNA into eukaryotic genomes |
US6664108B1 (en) | 1997-11-18 | 2003-12-16 | Pioneer Hi-Bred International, Inc. | Mobilization of viral genomes from T-DNA using site-specific recombination systems |
US6187994B1 (en) | 1997-11-18 | 2001-02-13 | Pioneer Hi-Bred International, Inc. | Compositions and methods for genetic modification of plants |
US8735158B2 (en) | 1997-11-18 | 2014-05-27 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
US8536420B2 (en) | 1997-11-18 | 2013-09-17 | Pioneer Hi-Bred International, Inc. | Compositions and methods for genetic modification of plants |
US7102055B1 (en) | 1997-11-18 | 2006-09-05 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
WO1999025840A1 (fr) * | 1997-11-18 | 1999-05-27 | Pioneer Hi-Bred International, Inc. | Nouveau procede d'integration d'adn etranger dans des genomes . |
US8143504B2 (en) | 1997-11-18 | 2012-03-27 | Pioneer Hi-Bred International, Inc. | Compositions and methods for genetic modification of plants |
US7179599B2 (en) | 1997-11-18 | 2007-02-20 | Pioneer Hi-Bred International, Inc. | Mobilization of viral genomes from T-DNA using site-specific recombination systems |
US7807868B2 (en) | 1997-11-18 | 2010-10-05 | Pioneer Hi-Bred International, Inc. | Mobilization of viral genomes from T-DNA using site-specific recombination systems |
US7223601B2 (en) | 1997-11-18 | 2007-05-29 | Pioneer Hi-Bred International, Inc. | Method for the integration of foreign DNA into eukaryotic genomes |
US7572634B2 (en) | 1997-11-18 | 2009-08-11 | Pioneer Hi-Bred International, Inc. | Compositions and methods for locating preferred integration sites within the genome of a plant |
US7462766B2 (en) | 1997-11-18 | 2008-12-09 | Pioneer Hi-Bred International, Inc. | Compositions comprising non-identical recombination sites |
US7361508B2 (en) | 1997-11-18 | 2008-04-22 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
US7364902B2 (en) | 1997-11-18 | 2008-04-29 | Pioneer Hi-Bred International, Inc, | Mobilization of viral genomes from T-DNA using site-specific recombination systems |
US7405079B2 (en) | 1997-11-18 | 2008-07-29 | Pioneer Hi-Bred International, Inc. | Compositions and methods to reduce the complexity of transgene integration into the genome of a plant |
EP1218488A4 (fr) * | 1999-09-21 | 2004-09-29 | Univ Rutgers | Systeme de recombinaison specifique au site permettant de manipuler le genome du plaste de plantes superieures |
WO2001040492A3 (fr) * | 1999-11-12 | 2002-02-07 | Univ Rockefeller | Recombinaison dirigee inductible destinee a l'activation et a l'elimination de transgenes de plantes transgeniques |
US7115798B1 (en) | 1999-11-17 | 2006-10-03 | E. I. Du Pont De Nemours And Company | Methods for regulated expression of triats in plants using multiple site-specific recombination systems |
WO2002016624A1 (fr) * | 2000-08-25 | 2002-02-28 | Institute Of Molecular Agrobiology | Reduction de la transmission de transgenes dans des plantes |
US7560622B2 (en) | 2000-10-06 | 2009-07-14 | Pioneer Hi-Bred International, Inc. | Methods and compositions relating to the generation of partially transgenic organisms |
US7238854B2 (en) | 2002-04-11 | 2007-07-03 | E. I. Du Pont De Nemours And Company | Method of controlling site-specific recombination |
US7267979B2 (en) | 2002-07-01 | 2007-09-11 | Pioneer Hi-Bred International, Inc. | Method of controlling gene silencing using site specific recombination |
EP2256189A1 (fr) | 2003-03-28 | 2010-12-01 | National Institute Of Agrobiological Sciences | Procédé de production d'un organe de stockage de plante avec une production élevée de dérivé de GLP-1 recombinant. |
CN1313610C (zh) * | 2004-06-24 | 2007-05-02 | 中国科学院微生物研究所 | 一种用于去除转基因植物中选择标记基因的方法 |
EP1669456A2 (fr) | 2004-12-11 | 2006-06-14 | SunGene GmbH | Cassettes d'expression pour l'expression preférentielle dans les méristèmes de plantes |
US8318493B2 (en) | 2005-07-18 | 2012-11-27 | Pioneer Hi-Bred International, Inc. | FRT recombination sites and methods of use |
US8586361B2 (en) | 2005-07-18 | 2013-11-19 | Pioneer Hi-Bred International, Inc. | FRT recombination sites and methods of use |
US7736897B2 (en) | 2005-07-18 | 2010-06-15 | Pioneer Hi-Bred International, Inc. | FRT recombination sites and methods of use |
US8900869B2 (en) | 2005-07-18 | 2014-12-02 | Pioneer Hi-Bred International, Inc. | FRT recombination sites and methods of use |
US9234194B2 (en) | 2005-07-18 | 2016-01-12 | Pioneer Hi-Bred International, Inc. | Modified FRT recombination site libraries and methods of use |
US9777284B2 (en) | 2005-07-18 | 2017-10-03 | Pioneer Hi-Bred International, Inc. | Modified FRT recombination site libraries and methods of use |
US7932434B2 (en) | 2007-08-15 | 2011-04-26 | Wisconsin Alumni Research Foundation | Late blight resistance gene from wild potato |
Also Published As
Publication number | Publication date |
---|---|
CA2073412A1 (fr) | 1993-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1993001283A1 (fr) | Plantes transgeniques sans genes de selection | |
US7115798B1 (en) | Methods for regulated expression of triats in plants using multiple site-specific recombination systems | |
Cocking et al. | Gene transfer in cereals | |
US5633440A (en) | P119 promoters and their uses | |
US5073675A (en) | Method of introducing spectinomycin resistance into plants | |
JP2672316B2 (ja) | 嫌気的植物調節因子 | |
US20020147168A1 (en) | Single-step excision means | |
WO1999061632A1 (fr) | Procede d'inhibition d'expression de genes | |
CA1309365C (fr) | Activateur de l'ocs | |
WO1991013991A1 (fr) | Promoteur pour plantes | |
US5658773A (en) | Tomato acid invertase gene | |
EP0240332A2 (fr) | Plantes résistantes aux virus comportant l'ARN anti-sens | |
US7238854B2 (en) | Method of controlling site-specific recombination | |
US5850018A (en) | Expression control sequence for general and effective expression of genes in plants | |
US5217902A (en) | Method of introducing spectinomycin resistance into plants | |
US5545815A (en) | Control of fruit ripening in plants | |
Hensgens et al. | Translation controls the expression level of a chimaeric reporter gene | |
US20040191912A1 (en) | New constitutive plant promoter | |
WO2002012450A1 (fr) | Promoteurs $i(gossypium hirsutum) specifiques du tissu et utilisation de ceux-ci | |
US5750873A (en) | Nucleic acid molecules that encode tassel seed 2(TS2), a protein involved in the control of flower development in plants | |
AU705682C (en) | An expression control sequence for general and effective expression of genes in plants | |
US7199235B2 (en) | Plant promoters | |
Hensgens et al. | Rice transformation, vectors, and expression of transferred genes | |
Jiang | T-DNA tagging in vivo: isolation and characterization of a putative plant promoter mediating gene expression in tobacco flowers | |
Zhou et al. | Functional analysis of the 3′-terminal sequence of the maize controlling element (Ac) by internal replacement and deletion mutagenesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase |